Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
Pfizer Dividend Yield 6.2%: Cash Flow Coverage and Valuations
Income investors examine healthcare sector cash flow metrics and dividend coverage ratios independently of broad market sector movements.
Based on reporting from yahoo-tickers-tape-movers.
Pfizer trades with a 6.2% dividend yield supported by $11 billion in trailing four-quarter free cash flow, outperforming dividend payout requirements despite a 35% five-year decline in share price. Investors examining healthcare sector valuations note the $27.41 current share price and $158 billion market capitalization against long-term operational cash generation.
Market context for this story
As of: After HoursLoading quotes…
Informational only — not investment advice. Full markets →
$XLVHealth Care Select Sector
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/XLV. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Pfizer shares changed hands at $27.41, retreating 1.40% or $0.39 during the session, amid broader market evaluation of healthcare sector valuations and income reliability.
### Session Tape — Pfizer PFE -1.40%
## Catalyst Analysis: Cash Flow Versus Payout Safety Market sentiment regarding Pfizer reflects a divergence between short-term equity performance—showing a greater than 10% gain over the trailing year—and a multi-year consolidation that leaves shares down 35% over five years. Underlying operational metrics indicate robust cash generation, with free cash flow reaching $11 billion over the past four quarters. This figure surpasses total dividend distributions by over $1 billion during the same timeframe, underpinning the sustainability of the quarterly dividend of $0.43 per share.
Recent per-share earnings of $0.77 comfortably exceed the quarterly payout threshold, keeping the 6.2% dividend yield (reported at 6.19%) insulated from immediate coverage pressures. Gross margins stand at 64.83%, while the company maintains a market capitalization of $158 billion on a volume of 31.9 million shares against a 36.8 million average.
### Money Play
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
Income investors examine healthcare sector cash flow metrics and dividen
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: October 5, 2026 at 4:31 PM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
healthcare dividend income
Pfizer is paying a high dividend of over 6%, and the company currently makes enough cash to pay it safely. Income-focused investors watch this closely because a high dividend is only good if the business can afford it.
What changed
Pfizer's strong free cash flow of $11 billion and quarterly earnings of $0.77 continue to cover its $0.43 dividend payout despite weak multi-year stock performance.
Who wins / who loses
Income-focused investors seeking high yields benefit from covered payouts, while growth investors holding the stock over the past five years face capital losses.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor, Side income / builder
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $PFEWatch — track, don’t rush
Pfizer pays a big dividend and makes enough cash to afford it, but the stock price hasn't grown much lately.
View $PFE chart → · End-of-day delayed data
Peer
- $LLYWatch — track, don’t rush
Other big drug companies are growing faster, though they pay smaller dividends.
View $LLY chart → · End-of-day delayed data
- $MRKWatch — track, don’t rush
Another major drug maker often compared with Pfizer for income and safety.
View $MRK chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Direction: range · Style: Covered-call income (only if you already own shares) · Level: intermediate
If you already own the stock and expect it to stay flat, you can collect extra cash by selling options on it. Beginners should stick to simply holding the stock for the dividend.
Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Review individual healthcare holdings for cash flow coverage ratios rather than relying solely on headline yields.
What would break this thesis
- A significant drop in free cash flow below total dividend obligations or unexpected patent cliffs impacting earnings.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).